Compare trusted PT-141 (bremelanotide) providers with transparent editorial analysis, pricing, and clinician-oversight details.
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
When comparing PT-141 providers, prioritize licensed-clinician oversight, sourcing from a licensed US compounding pharmacy, transparent all-in pricing, personalized as-needed dosing guidance, and responsive medical support.
Complete a short online intake, have your case reviewed by a US-licensed clinician, and, if appropriate, receive a personalized as-needed PT-141 protocol shipped from a licensed US pharmacy with ongoing dosing support.
PT-141, or bremelanotide, is a melanocortin receptor agonist that acts on the central nervous system's arousal pathways rather than on blood flow. It is used to address low sexual desire, and its branded form, Vyleesi, is FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women.
ED medications such as sildenafil and tadalafil are PDE5 inhibitors that improve blood flow. PT-141 works through a different mechanism, activating melanocortin (primarily MC4R) receptors in the brain to influence the desire and arousal signal itself, not the vascular response.
PT-141 is typically prescribed as an as-needed subcutaneous injection taken ahead of intimacy, rather than a daily medication. A licensed clinician sets your starting dose and timing and adjusts based on how you respond.
Bremelanotide is FDA-approved as the branded product Vyleesi for HSDD in premenopausal women. Compounded PT-141 prescribed through telehealth providers is not itself FDA-approved; it is prepared by a licensed US compounding pharmacy and requires a prescription from a licensed clinician.
Look at clinician oversight, pharmacy sourcing, transparent total pricing, dosing guidance, and support responsiveness. TelosRx leads our ranking with clinician-prescribed, as-needed compounded PT-141 from a licensed US pharmacy, free 48-hour shipping, FSA/HSA eligibility, and 24/7 doctor messaging.
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →Some links are affiliate links and may generate commission at no extra cost to you. Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care. Bremelanotide is FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women; compounded PT-141 is not FDA-approved. A licensed clinician determines whether treatment is appropriate. Results may vary and are not guaranteed. Advertising disclosure.
Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment. We may earn a commission from partner links on this page - see our advertising disclosure.